Palatin Technologies Inc (PTN): Depreciation & Amortization
$62.7K
Year ended 2026-06-30
$65.2K
Trailing 12 months to 2026-09-30
-39.9%
3-year compound annual growth
+4.2%
5-year compound annual growth
+3.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $62.7K | -75.8% | 2026-09-28, From 2025-07-01 |
| 2025-06-30 | $258.9K | -23.6% | 2026-09-28, From 2024-07-01 |
| 2024-06-30 | $339.1K | +17.6% | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | $288.3K | +127.6% | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | $126.7K | +147.8% | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | $51.1K | -20.4% | 2022-09-22, From 2020-07-01 |
| 2020-06-30 | $64.2K | +9.5% | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | $58.6K | +3.7% | 2020-09-25, From 2018-07-01 |
| 2018-06-30 | $56.6K | +71.2% | 2020-09-25, From 2017-07-01 |
| 2017-06-30 | $33.1K | -23.2% | 2019-09-12, From 2016-07-01 |
| 2016-06-30 | $43.1K | -63.4% | 2018-09-13, From 2015-07-01 |
| 2015-06-30 | $117.6K | +5.1% | 2017-09-25, From 2014-07-01 |
| 2014-06-30 | $111.9K | +0.1% | 2016-09-19, From 2013-07-01 |
| 2013-06-30 | $111.8K | -88.2% | 2015-09-18, From 2012-07-01 |
| 2012-06-30 | $949.5K | -16.6% | 2014-09-12, From 2011-07-01 |
| 2011-06-30 | $1.14M | -10.3% | 2013-09-27, From 2010-07-01 |
| 2010-06-30 | $1.27M | n/a | 2012-09-10, From 2009-07-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2026-06-30 | $62.7K | -75.8% |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $1.90M | -34.5% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $600.0K | +20.0% |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $192.0K | -42.5% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $4.51M | +51.3% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | $39.0K | +77.3% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $1.71M | -3.4% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $1.91M | +0.7% |
| uniQure N.V. (QURE) | 2025-12-31 | $14.76M | +16.8% |
Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗